Abbott Reports Third-Quarter 2025 Results and Reaffirms Full-Year Guidance
Go back to Abbott Reports Third-Quarter 2025 Results and Reaffirms Full-Year Guidance| Abbott Laboratories (NYSE: ABT) | Delayed: 90.31 +2.48 (2.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $87.83 | 52 Week High | $46.38 | |||
| Open | $88.95 | 52 Week Low | $36.00 | |||
| Day High | $90.59 | P/E | 60.21 | |||
| Day Low | $88.73 | EPS | $1.50 | |||
| Volume | 4,350,621 | |||||
